Chugai Pharmaceutical Co Ltd (CHGCF)
29.75
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
Chugai Pharmaceutical Price to Book Value: 4.512 for May 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 4.512 |
| May 23, 2024 | 4.512 |
| May 22, 2024 | 4.512 |
| May 21, 2024 | 4.512 |
| May 20, 2024 | 4.512 |
| May 17, 2024 | 4.512 |
| May 16, 2024 | 4.512 |
| May 15, 2024 | 4.512 |
| May 14, 2024 | 4.512 |
| May 13, 2024 | 4.918 |
| May 10, 2024 | 4.918 |
| May 09, 2024 | 4.918 |
| May 08, 2024 | 4.918 |
| May 07, 2024 | 4.918 |
| May 06, 2024 | 4.918 |
| May 03, 2024 | 4.918 |
| May 02, 2024 | 4.918 |
| May 01, 2024 | 4.918 |
| April 30, 2024 | 4.918 |
| April 29, 2024 | 4.918 |
| April 26, 2024 | 4.918 |
| April 25, 2024 | 4.918 |
| April 24, 2024 | 4.918 |
| April 23, 2024 | 5.046 |
| April 22, 2024 | 5.046 |
| Date | Value |
|---|---|
| April 19, 2024 | 5.046 |
| April 18, 2024 | 5.046 |
| April 17, 2024 | 5.046 |
| April 16, 2024 | 5.046 |
| April 15, 2024 | 5.046 |
| April 12, 2024 | 5.046 |
| April 11, 2024 | 5.936 |
| April 10, 2024 | 5.936 |
| April 09, 2024 | 5.936 |
| April 08, 2024 | 5.936 |
| April 05, 2024 | 5.936 |
| April 04, 2024 | 5.936 |
| April 03, 2024 | 5.936 |
| April 02, 2024 | 5.936 |
| April 01, 2024 | 5.936 |
| March 31, 2024 | |
| March 28, 2024 | 5.587 |
| March 27, 2024 | 5.587 |
| March 26, 2024 | 5.587 |
| March 25, 2024 | 5.587 |
| March 22, 2024 | 5.587 |
| March 21, 2024 | 5.587 |
| March 20, 2024 | 5.932 |
| March 19, 2024 | 5.932 |
| March 18, 2024 | 5.932 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.746
Minimum
Mar 14 2023
10.44
Maximum
Jul 06 2020
5.504
Average
5.030
Median
Apr 26 2022
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.8568 |
| Nxera Pharma Co Ltd | 1.833 |
| PeptiDream Inc | 5.915 |
| Healios KK | 3.615 |
Price to Book Value Related Metrics
| PE Ratio | 21.64 |
| PS Ratio | 6.813 |
| Price to Free Cash Flow | 21.99 |
| Price | 29.75 |
| Earnings Yield | 4.62% |
| Market Cap | 48.95B |
| Operating PE Ratio | 16.02 |
| Normalized PE Ratio | 21.64 |